Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
Alum adjuvant: some of the tricks of the oldest adjuvantJournal of medical microbiology, 2012-07, Vol.61 (Pt 7), p.927-934 [Peer Reviewed Journal]ISSN: 0022-2615 ;EISSN: 1473-5644 ;DOI: 10.1099/jmm.0.038943-0 ;PMID: 22174375Full text available |
|
2 |
Material Type: Article
|
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older AdultsThe New England journal of medicine, 2023-02, Vol.388 (7), p.595-608 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2209604 ;PMID: 36791160Full text available |
|
3 |
Material Type: Article
|
Perioperative Pembrolizumab for Early-Stage Non–Small-Cell Lung CancerThe New England journal of medicine, 2023-08, Vol.389 (6), p.491-503 [Peer Reviewed Journal]Copyright © 2023 Massachusetts Medical Society. All rights reserved. ;Copyright © 2023 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2302983 ;PMID: 37272513Full text available |
|
4 |
Material Type: Article
|
Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced MelanomaJournal of clinical oncology, 2015-09, Vol.33 (25), p.2780-2788 [Peer Reviewed Journal]2015 by American Society of Clinical Oncology. ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2014.58.3377 ;PMID: 26014293Full text available |
|
5 |
Material Type: Article
|
Efficacy and Safety of a Recombinant Plant-Based Adjuvanted Covid-19 VaccineNew England Journal of Medicine, 2022-06, Vol.386 (22), p.2084-2096 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2022 Massachusetts Medical Society ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2022 Massachusetts Medical Society. All rights reserved. 2022 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2201300 ;PMID: 35507508Digital Resources/Online E-Resources |
|
6 |
Material Type: Article
|
Tumor-killing nanoreactors fueled by tumor debris can enhance radiofrequency ablation therapy and boost antitumor immune responsesNature communications, 2021-07, Vol.12 (1), p.4299-4299, Article 4299 [Peer Reviewed Journal]2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-24604-9 ;PMID: 34262038Full text available |
|
7 |
Material Type: Article
|
pH-degradable imidazoquinoline-ligated nanogels for lymph node-focused immune activationProceedings of the National Academy of Sciences - PNAS, 2016-07, Vol.113 (29), p.8098-8103 [Peer Reviewed Journal]Volumes 1–89 and 106–113, copyright as a collective work only; author(s) retains copyright to individual articles ;Copyright National Academy of Sciences Jul 19, 2016 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1600816113 ;PMID: 27382168Full text available |
|
8 |
Material Type: Article
|
Adjuvants: Classification, Modus Operandi, and LicensingJournal of immunology research, 2016-01, Vol.2016, p.1459394-16 [Peer Reviewed Journal]Copyright © 2016 Juliana de Souza Apostólico et al. ;Copyright © 2016 Juliana de Souza Apostolico et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. ;Copyright © 2016 Juliana de Souza Apostólico et al. 2016 ;ISSN: 2314-8861 ;EISSN: 2314-7156 ;DOI: 10.1155/2016/1459394 ;PMID: 27274998Full text available |
|
9 |
Material Type: Article
|
The perfect mix: recent progress in adjuvant researchNature reviews. Microbiology, 2007-07, Vol.5 (7), p.505-397 [Peer Reviewed Journal]Copyright Nature Publishing Group Jul 2007 ;ISSN: 1740-1526 ;EISSN: 1740-1534 ;DOI: 10.1038/nrmicro1681 ;PMID: 17558426Full text available |
|
10 |
Material Type: Article
|
TLR-based immune adjuvantsVaccine, 2011-04, Vol.29 (17), p.3341-3355 [Peer Reviewed Journal]2010 ;Published by Elsevier Ltd. ;Copyright Elsevier Limited Apr 12, 2011 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2010.08.002 ;PMID: 20713100Full text available |
|
11 |
Material Type: Article
|
New generation adjuvants – From empiricism to rational designVaccine, 2015-06, Vol.33, p.B14-B20 [Peer Reviewed Journal]Elsevier Ltd ;2015 Elsevier Ltd ;Copyright © 2015 Elsevier Ltd. All rights reserved. ;Copyright Elsevier Limited Jun 8, 2015 ;ISSN: 0264-410X ;EISSN: 1873-2518 ;DOI: 10.1016/j.vaccine.2015.01.088 ;PMID: 26022561Full text available |
|
12 |
Material Type: Article
|
Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myelomaBlood, 2002-11, Vol.100 (9), p.3063-3067 [Peer Reviewed Journal]2002 American Society of Hematology ;2003 INIST-CNRS ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2002-03-0996 ;PMID: 12384400Full text available |
|
13 |
Material Type: Article
|
CpG DNA as a vaccine adjuvantExpert review of vaccines, 2011-04, Vol.10 (4), p.499-511 [Peer Reviewed Journal]Expert Reviews Ltd 2011 ;COPYRIGHT 2011 Expert Reviews Ltd. ;ISSN: 1476-0584 ;EISSN: 1744-8395 ;DOI: 10.1586/erv.10.174 ;PMID: 21506647Full text available |
|
14 |
Material Type: Article
|
Sedimentation behavior of quality and freeze-damaged aluminum-adjuvanted vaccines by w NMRHuman vaccines & immunotherapeutics, 2023-08, Vol.19 (2), p.2215152 [Peer Reviewed Journal]ISSN: 2164-5515 ;EISSN: 2164-554X ;DOI: 10.1080/21645515.2023.2215152 ;PMID: 37254504Full text available |
|
15 |
Material Type: Article
|
Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical TrialsJAMA, 2020-09, Vol.324 (10), p.951 [Peer Reviewed Journal]2020. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://jamanetwork.com/journals/jama/pages/coronavirus-alert . ;DOI: 10.1001/jama.2020.15543Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Long term adjuvant endocrine therapy and risk of cardiovascular disease in female breast cancer survivors: systematic reviewBMJ (Online), 2018-10, Vol.363, p.k3845 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions 2018 BMJ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to 2018 BMJ ;ISSN: 0959-8138 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.k3845 ;PMID: 30297439Full text available |
|
17 |
Material Type: Article
|
Molecular identification of a danger signal that alerts the immune system to dying cellsNature, 2003-10, Vol.425 (6957), p.516-521 [Peer Reviewed Journal]COPYRIGHT 2003 Nature Publishing Group ;Copyright Macmillan Journals Ltd. Oct 2, 2003 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature01991 ;PMID: 14520412 ;CODEN: NATUASFull text available |
|
18 |
Material Type: Article
|
Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehiclesNucleic acids research, 2014-09, Vol.42 (15), p.9996-10004 [Peer Reviewed Journal]The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research. ;The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research. 2014 ;ISSN: 0305-1048 ;EISSN: 1362-4962 ;DOI: 10.1093/nar/gku516 ;PMID: 25092921Full text available |
|
19 |
Material Type: Article
|
Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant TherapyThe New England journal of medicine, 2016-11, Vol.375 (19), p.1845-1855 [Peer Reviewed Journal]Copyright © 2016 Massachusetts Medical Society. All rights reserved. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1611299 ;PMID: 27717298Full text available |
|
20 |
Material Type: Article
|
Adjuvant Pembrolizumab versus Placebo in Resected Stage III MelanomaThe New England journal of medicine, 2018-05, Vol.378 (19), p.1789-1801 [Peer Reviewed Journal]Copyright © 2018 Massachusetts Medical Society. All rights reserved. ;(c) Massachusetts Medical Society, 2018 info:eu-repo/semantics/openAccess ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1802357 ;PMID: 29658430Full text available |